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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S269No signiﬁcant interactions were found between race or gender and
radiographic knee, hip, or hand OA with lumbar spine IRF.
Conclusion: Interestingly, the strongest associations were found between
OA of the facet joints of the spine, which are synovial joints, and OA of both
the knees andhands, also synovial joints. Theseﬁndings also suggest that hip
OA may have a different etiology from that of lumbar spine IRF; this is not
surprising given the prevalence of morphometric abnormalities cited as
a common etiology for hip OA. The fact that lumbar OST, but not DSN, were
associatedwith kneeOAmay inpart bedue to relianceonK-L grade, a system
weighted for the presence of osteophyte, for deﬁning OA of the knee.
Nevertheless, these ﬁndings underscore the importance of analyzing lumbar
spine IRF as separate outcomes for OA studies as they likely reﬂect different
processes ongoing in the joint organ during the course of this disease.Table. Adjusted associations between lumbar spine IRF and radiographic knee,
hip and hand OA
DSN OR(95% CI) OST OR(95% CI) FOA OR(95% CI)
Knee OA 1.16 (0.84, 1.59) 1.62 (1.16, 2.27) 1.69 (1.15, 2.49)
Hip OA 0.99 (0.71, 1.38) 1.01 (0.72, 1.43) 0.89 (0.60, 1.31)
Hand OA 1.14 (0.79, 1.63) 0.81 (0.55, 1.18) 1.82 (1.15, 2.89)532
DIAGNOSIS OF LUMBAR SPINAL STENOSIS: AN UPDATED SYSTEMATIC
REVIEW
E. de Schepper 1, G. Overdevest 2, P. Suri 3, W. Peul 2, E. Oei 1, B. Koes 1, S.
Bierma-Zeinstra 1, P. Luijsterburg 1. 1 Erasmus MC, Rotterdam, Netherlands;
2 Leiden Univ. Med. Ctr., Leiden, Netherlands; 3Harvard Med. Sch., Boston,
MA, USA
Purpose: To update our previous systematic review on the diagnostic
accuracy of tests used to diagnose lumbar spinal stenosis. A wide range of
clinical, radiologic and electrodiagnostic tests are used to diagnose lumbar
spinal stenosis. An accurate diagnosis is vital, because lumbar spinal
stenosis may require speciﬁc medical advice and treatment. Therefore, it is
important toknowthe accuracyof thesediagnostic tests currentlyavailable.
Methods: A comprehensive literature search was conducted for original
diagnostic studies on lumbar spinal stenosis, inwhichoneormorediagnostic
testswere evaluatedwith a reference standard, anddiagnostic accuracywere
reportedor could be calculated.Ourprevious systematic reviewwasupdated
up to March 2004, this review up to March 2011. Two reviewers indepen-
dently checked all eligible articles for inclusion criteria. Included studies
were assessed for their methodological quality using the Quadas tool. Study
characteristics and reported diagnostic accuracy were extracted.
Results: Twenty-two additional articles over the 24 included in the
previous review met the inclusion criteria. Combined, this resulted in
twenty articles concerning imaging tests, 11 articles evaluating electro-
diagnostic tests, and 15 articles evaluating clinical tests. Estimates of the
diagnostic accuracy of the tests differed considerably. Because of the
heterogeneity of the tests, study population, and reference standards,
statistical pooling of results was not possible.
Conclusions: At present the most promising test for lumbar spinal stenosis is
MRI, avoiding myelography because of its invasiveness and lack of superior
accuracy. Electrodiagnostic studies showed no superior accuracy for conven-
tional electrodiagnostic testing compared to MRI. The most useful clinical
ﬁndings for ruling in the diagnosis of lumbar spinal stenosis are billateral
buttock or leg pain, the absence of pain when seated, the improvement of
symptoms when bending forward, and a wide-based gait are the most useful
individual ﬁndings for ruling in the diagnosis of lumbar spinal stenosis.
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IMMEDIATE EFFECTS OF MOTION STYLE ACUPUNCTURE TREATMENT
(MSAT) IN ACUTE LOW BACK PAIN WITH SEVERE DISABILITY:
A MULTICENTER, RANDOMIZED, CONTROLLED TRIAL
T.-G. Lee 1, J.-S. Shin 1, I.-H. Ha 1, Y. Choi 2, B.-Y. Park 1, M.-R. Kim 1, B.-C.
Shin 3, M. Lee 4. 1 Jaseng Hosp. of Oriental Med., Seoul, Republic of Korea;
2 Jaseng Med. Fndn., Seoul, Republic of Korea; 3 Pusan Natl. Univ., Pusan,
Republic of Korea; 4Korea Inst. of Oriental Med., Daejeon, Republic of KoreaPurpose: Acupuncture is widely-used to treat patients with low back pain
(LBP), despite insufﬁcient evidence of its efﬁcacy for acute LBP (aLBP).
Motion style acupuncture treatment (MSAT) requires a patient to exercise
while receiving acupuncture, a special style of non-traditional acupunc-
ture. This study aimed to evaluate the effects of MSAT on aLBP with severe
disability where the effect of acupuncture has not been conﬁrmed.
Methods: Fifty-eight aLBP participants with severe functional disability,
deﬁned as an Oswestry Disability Index (ODI) value>60%, were randomly
allocated to either MSATgroup (n¼29) or conventional diclofenac injection
group (n¼29). All procedures were limited to one session and results were
assessed before and 30 minutes after treatment. The primary outcomewas
measured using the numerical rating scale (NRS) for aLBP intensity.
Secondary outcomes weremeasured using the NRS for leg pain intensity, if
exists, and ODI for functional impairment.
Results: At 30 minutes after treatment, the MSAT group experienced
a signiﬁcant reduction in the NRS for LBP, radicular pain and ODI scores;
3.82.1 (p<.001), 1.21.9 (p¼.001), and 33.515.2% (p<.001), respectively.
In the diclofenac injection group, the NRS for LBP decreased by 0.71.1
(P¼.002), but not in radicular pain and ODI scores; 0.30.7 (P¼.055), and
0.46.6% (P¼.866), respectively. In addition, the NRS of LBP (p<.001),
radicular pain (p¼.008) and ODI scores (p<.001) of the MSAT group were
signiﬁcantly lower than those of the diclofenac injection group.
Conclusions: These results suggest that MSAT has positive effects on
immediate pain relief and the recovery of functional status of patients with
aLBP and severe disability. Whether MSAT is superior to traditional
acupuncture for aLBP is encouraged as future research matter.
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DO THE PREVALENCE RATES OF SYMPTOMATIC FACET JOINT
ARTHROPATHY AND ASYMPTOMATIC FACET JOINT ARTHROPATHY
CONCUR?
M.J. DePalma 1, J.M. Ketchum2. 1Virginia Spine Res. Inst., Inc, Richmond, VA,
USA; 2Dept. of Biostatistics, Virginia Commonwealth Univ., Richmond, VA, USA
Purpose: Lumbar facet joints are responsible for chronic low back pain in
approximately 15% of young adults and 32% of older adults. Imaging
studies have demonstrated that arthritic changes preferentially affect the
L45 level followed by L5S1 then L34. Such changes as demonstrated by
computed tomography have been shown to not correlate with facet joints
that are painful. A better understanding of whether the prevalence of
arthritic changes on imaging studies agrees with prevalence rates of
painful facet joint arthritis as determined by validated diagnostic blocks
will help direct treatment interventions. The purpose of this study was to
compare the prevalence of painful facet joint arthropathy (FJA) in symp-
tomatic adults to published prevalence rates of facet joint osteoarthritis
(FJOA) in asymptomatic adults.
Methods: A retrospective chart reviewwas conducted of consecutive CLBP
patients having undergone deﬁnitive diagnostic procedures after pre-
senting to an interventional spine care practice. Patients either underwent
provocation lumbar discography, dual diagnostic medial branch blocks
with local comparative anesthetics, or intra-articular diagnostic SIJ injec-
tions employing strict operational criteria to conﬁrm a source of LBP.
Clinical characteristics and physical exam ﬁndings were used to determine
which injection to perform ﬁrst and then sequentially if necessary. Cases
without deﬁnitive diagnosis were not considered in this analysis. The
prevalence rates for painful FJA in our symptomatic sample were esti-
mated with 95% conﬁdence intervals (CI) for the symptomatic group and
compared to historical asymptomatic rates using a chi-square test.
Results: The chart review included a total of 378 cases from 358 patients
presenting with CLBP whose low back disorder was deﬁnitively diagnosed.
The mean age was 52.8 years (SD ¼ 15.0) and the median duration of LBP
was 12months (IQR¼ 6-24). There were 208 cases not included in analysis
because deﬁnitive diagnostic injections were not completed as patients
improved clinically. The estimated prevalence rate of FJAwas 30.6% (95% CI
¼ 24.2%, 37.9%). CLBP was documented on the left side in 24 FJA cases
(46%), right in 16 cases (31%), and bilaterally in 12 cases (23%).
Prevalence rates of asymptomatic FJOA have been reported by level to be
15.1% for L23, 30.6% for L34, 45.1% for L45, and 38.2% for L5S1 (Kalichman).
Based on our sample, the prevalence of symptomatic FJA by level was
estimated to be 25% for L12 (95% CI ¼ 4.6%, 69.9%), 39.5% for L45 (95% CI ¼
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S27025.6%, 55.3%), and 55.6% for L5S1 (95% CI¼ 43.3%, 67.2%); two level FJAwas
not observed. The prevalence was signiﬁcantly greater at the L5S1 level for
symptomatic FJA than asymptomatic FJOA (p<0.01); the rates were not
signiﬁcantly different at level L45 (p¼0.49). Comparisons were not per-
formed at other levels since FJA/FJOA was not observed in both groups.
Conclusion: CLBP due to FJA most commonly occurs at L5S1. Morphologic
abnormalities indicative of FJOA in asymptomatic adults occur most
commonly at L45. These ﬁndings suggest that arthritic changes alone are
not the sole etiologic factor mitigating FJA related CLBP.
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LAMIN A DEREGULATION IN HUMAN MESENCHYMAL STEM CELLS
PROMOTES AN IMPAIRMENT IN THEIR CHONDROGENIC POTENTIAL
AND IMBALANCE IN THEIR RESPONSE TO OXIDATIVE STRESS
J. Mateos 1, A. De la Fuente 2, I.A. Lesende-Rodríguez 2, M. Arufe 2,3,
F.J. Blanco 1,3. 1Rheumatology Div., Proteomics Unit-ProteoRed/ISCIII INIBIC-
CHUAC, A Coruña, Spain; 2Dept. of Med., Area of Anatomy and Human
Embryology, University of A Coruña, Spain; 3Rheumatology Div., Cellular
Therapy Unit, CIBER-BBN/ISCIII, INIBIC-CHUAC, A Coruña, Spain
Purpose: Previous work by our group and others indicated that an accumu-
lation of lamin A (LMNA) was associated with the osteoarthritis (OA) chon-
drocyte phenotype. Mutations of this protein are linked to laminopathies and
speciﬁcally to Hutchinson-Guilford Progeria Syndrome (HGPS), an accelerated
agingdisease. Someauthorshaveproposed that aderegulationof LMNAaffects
the differentiation potential of stem cells. In the present study, we examined
the effect of the over-expression of LMNA, or itsmutant formprogerin (PG), on
the mesoderm differentiation potential of MSCs.
Methods:Mesenchymal stem cells (MSCs) from human umbilical cord (UC)
stroma have previously been isolated, expanded and differentiated towards
mesoderm cell lineages. For efﬁcient gene delivery of wt LMNA, PG and GFP
(Green Fluorescence Protein), we used a lentiviral expression system. GFP-
transducedMSCswereusedas control for thedifferentiation study since they
present a differentiation capacity similar to that of untransduced MSCs.
Osteogenic potential was studied by with alizarin red staining to assess
calcium deposits as well as Real-Time PCR of ALP, OC and Runx2 to assess
early and late osteogenic differentiation. Adipogenic potential was studied
with Oil Red staining for lipid droplets and Real-Time PCR of LPL, FABP and
ADIPOQ, for early and late adipogenic differentiation. Chondrogenesis and
hypertrophywere studied using immunohistochemestry and Real-Time PCR
of Aggrecan, MMP-13, Type II Collagen, Type I Collagen and Type I Collagen.
Results: We found that over-expression of LMNA or PG by lentiviral gene
delivery leads to defects in differentiation potential. PG-transduced MSCs
present defects in adipogenic and osteogenic potential, The chondrogenic
potential is defective in PG-MSCs, which present a decrease in COL2 and
Aggrecan as revealed by both immunohistochemystry and Real-Time PCR.
LMNA and PG-transduced MSCs have an increase in hypertrophy markers
(MMP-13 and Type X Collagen) during chondrogenic differentiation, as
well as a decrease in manganese superoxide dismutase (MnSODM) and an
increase of mitochondrial MnSODM-dependent reactive oxygen species
(ROS). ROS synthesis was partially (51%) and totally reverted by N-Acetyl
Cystein, ROS scavenger, (NAC) at 20 and 40 mg/mL respectively for 1 hour in
culture. In addition, defects in chondrogenesis detected by immunohis-
tochemestry and Real Time-PCR are partially reversed by incubations with
NAC at 40 mg/mL for 1 hour.
Conclusions: Our results suggest that OA process could be enhanced by
defects in stem cell differentiation, partially due to imbalance in oxidative
stress.
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SYNGENEIC, MINOR MISMATCHED, AND MAJOR MISMATCHED
TRANSPLANTATION OF MESENCHNMAL STEM CELLS DERIVED FROM
SYNOVIUM IN A RAT MASSIVE MENISCAL DEFECT MODEL
M. Okuno 1,2, I. Sekiya 3, S. Yoshiya 2, T. Muneta 1. 1Orthopaedic Surgery,
Tokyo Med. ana Dental Univ., Tokyo, Japan; 2Orthopaedic Surgery, Hyogo
Coll. of Med., Hyogo, Japan; 3Cartilage Regeneration, Tokyo Med. ana
Dental Univ., Tokyo, JapanPurpose: We previously reported that intraarticular injection of mesen-
chymal stem cells (MSCs) derived from synovium promoted meniscal
regeneration in a rat massive meniscal defect model
Great number of reports described that bone marrow MSCs had immu-
noprivileged effects as well as immunosuppressive effects and that allo-
geneic transplantation of bone marrow MSCs enhanced regeneration in
injury models. However, this is still controversial, and the opposite results
were also reported. As far as synovial MSCs, the inﬂuence of allogeneic
transplantation have not been investigated at all.
In this study, we performed syngeneic transplantation and allogeneic
transplantation of synovial MSCs into the knee joints whose medial
menisci were removed. The area of regenerated menisci were compared
among the allogeneic transplantation groups, the major antigen mismatch
group and the minor antigen mismatch group.
Methods: Cell isolation and culture. This study was approved by institu-
tional animal use committee. Synoviumwas harvested from the knee joint
of 3 strains, F344, Lewis, and ACI rats. After collagenase digestion, nucle-
ated cells derived from synoviumwere expanded and colony forming cells
were collected for transplantation.
Meniscectomy: As recipients, only F344 rats at 10-12 weeks of age were
used. Under anesthesia, a straight incisionwasmade on the anterior side of
the right knee, the anteromedial side of the joint capsule was cut, and the
anterior horn of the medial meniscus was dislocated anteriorly with
a forceps. The meniscus was then cut vertically at the level of medial
collateral ligament, and anterior half of medial meniscus was removed.
Transplantation: Immediately after the skin incision was closed, 5x106
synovial MSCs in 50 ml PBS were injected into the right knee joint of F344
rats. Transplantation of synovial MSCs derived from F344 rat is a syngeneic
model. Transplantation of synovial MSCs derived from Lewis rat is a minor
antigen mismatch model, in which histocompatibility antigens differ partly.
Transplantation of synovial MSCs derived from ACI rat is a major antigen
mismatch model, in which histocompatibility antigens differ greatly.
Macroscopic and microscopic features for menisci were examined, and
regenerative area ofmenisci wasmeasured 4weeks after the surgery. (n¼6).
Results :In the case of synovial MSCs derived from F344 and Lewis rat were
transplanted, into the knee of F344 rat, the regenerative areawas signiﬁcantly
larger in the transplantation side than in the contrateral side (n¼6; p¼0.034).
Contrarily, in the case of synovialMSCsderived fromACI ratwere transplanted,
into thekneeof F344 rat, therewasno signiﬁcantdifferenceof the regenerative
area between in the transplantation side and in the contralateral side. The
regenerative area of medial meniscus in the ACI transplantation group was
signiﬁcantly smaller than in the F344 and ACI groups (n¼6; p<0.03).
Conclusion: For regeneration of removed meniscus, similar results were
obtained between the syngeneic transplantation and the minor mismatch
transplantation model. In the major mismatch model, the results were
inferior to the other models.
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CHONDROGENIC DIFFERENTIATION POTENTIAL OF CD56+ SATELLITE
CELL AND PDGFRa+ MESENCHYMAL STEM CELL DERIVED FROM
HUMAN SKELETAL MUSCLE
T. Oishi 1, A. Uezumi 2, A. Kanaji 1, K. Tsuchida 2, H. Yamada 1. 1Dept. of
Orthopaedics, Fujita Hlth.Univ., Sch. of Med., Toyoake-city, Aichi, Japan;
2Div. for Therapies against Intractable Disease, Inst. for Comprehensive
Med. Sci., Fujita Hlth.Univ., Toyoake-city, Aichi, Japan
Purpose: We recently identiﬁed that murine-derived platelet derived
growth factor-a positive mesenchymal stem cells (PDGFRa+ cells) have the
capacity for adipogenic and osteogenic differentiation in vitro and vivo
(Nature Cell, 2010). We also previously reported that two distinct stem cells,
CD56+ satellite cells and PDGFRa+ cells were identiﬁed in human skeletal
muscle and the human PDGFRa+ cells showed successful engraftment and
bone-like tissue formation in vivo. However, chondrogenic differentiation
potential of human skeletal muscle-derived stem cell is still unknown. The
purpose of this study is that the CD56+ satellite cells and PDGFRa+
mesenchymal stem cells derived from human skeletal muscle are evaluated
for their capacity for chondrogenic differentiation in vitro.
Methods:In this study, we used the human muscular tissue of patients
with osteoarthritis of hip, after informed consent were obtained at the
time of hip surgery. After enzymatic digestion of human skeletal muscle,
